Novanta Inc. (NASDAQ:NOVT – Get Free Report) CEO Matthijs Glastra sold 6,500 shares of Novanta stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $130.05, for a total transaction of $845,325.00. Following the transaction, the chief executive officer owned 56,761 shares of the company’s stock, valued at $7,381,768.05. The trade was a 10.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Matthijs Glastra also recently made the following trade(s):
- On Tuesday, February 10th, Matthijs Glastra sold 7,500 shares of Novanta stock. The shares were sold at an average price of $145.04, for a total transaction of $1,087,800.00.
- On Wednesday, January 21st, Matthijs Glastra sold 7,500 shares of Novanta stock. The shares were sold at an average price of $140.00, for a total transaction of $1,050,000.00.
Novanta Price Performance
Shares of NOVT opened at $133.19 on Thursday. The company has a market capitalization of $4.75 billion, a P/E ratio of 91.23 and a beta of 1.64. The company has a quick ratio of 2.80, a current ratio of 3.69 and a debt-to-equity ratio of 0.16. The firm has a 50 day moving average of $127.97 and a 200 day moving average of $123.15. Novanta Inc. has a twelve month low of $98.27 and a twelve month high of $149.95.
Institutional Investors Weigh In On Novanta
Several institutional investors and hedge funds have recently bought and sold shares of NOVT. Pilgrim Partners Asia Pte Ltd purchased a new stake in Novanta in the 3rd quarter worth approximately $36,000. Migdal Insurance & Financial Holdings Ltd. purchased a new stake in Novanta in the 3rd quarter worth approximately $40,000. Danske Bank A S purchased a new stake in Novanta in the 3rd quarter worth approximately $40,000. Allworth Financial LP lifted its holdings in Novanta by 978.4% in the 4th quarter. Allworth Financial LP now owns 399 shares of the technology company’s stock worth $47,000 after buying an additional 362 shares during the period. Finally, EverSource Wealth Advisors LLC raised its position in shares of Novanta by 120.1% in the 4th quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company’s stock worth $51,000 after acquiring an additional 233 shares in the last quarter. Hedge funds and other institutional investors own 98.35% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the stock. Wall Street Zen downgraded shares of Novanta from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a research report on Friday, April 17th. Zacks Research raised shares of Novanta from a “strong sell” rating to a “hold” rating in a research report on Friday, January 16th. Finally, Robert W. Baird raised shares of Novanta from a “neutral” rating to an “outperform” rating and cut their price objective for the company from $150.00 to $144.00 in a research report on Monday, March 30th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $144.00.
View Our Latest Report on Novanta
Novanta Company Profile
Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
Further Reading
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
